Norris Medicines Ltd.

Financial

	Norris Medicines	Emmessar Biotech&Nut	Chemo Pharma Labs
Operational Metrics
Financials
5 yr Average ROE	47.03 %	13.7 %	-4.51 %
5yr average Equity Multiplier	-2.46	1.24	1.01
5yr Average Asset Turnover Ratio	0.6	0.36	0.0
5yr Avg Net Profit Margin	-30.66 %	71.53 %	0.0
Price to Book	0.0	2.08	1.37
P/E	0.0	41.06	0.0
5yr Avg Cash Conversion Cycle	97.28 Days	68.18 Days	0.0
Inventory Days	165.43 Days	62.21 Days	0.0
Days Receivable	69.98 Days	10.88 Days	0.0
Days Payable	260.51 Days	199.95 Days	0.0
5yr Average Interest Coverage Ratio	-1.37	815.2	794.39
5yr Avg ROCE	-19.87 %	19.97 %	-3.17 %
5yr Avg Operating Profit Margin	-6.94 %	-101.39 %	0.0
5 yr average Debt to Equity	-3.0	0.0	0.01
5yr CAGR Net Profit	-15.97 %	0.0	n/a
5yr Average Return on Assets	-18.92 %	10.86 %	-4.13 %
Shareholdings
Promoter Holding	34.0 %	59.53 %	27.89 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.04 %	1.34 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0